Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-22

Clinical Trial Update: Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial results evaluating the impact of different exercise doses with metformin on vascular health in metabolic syndrome; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Rutgers University | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-09-22